Triamcinolone or Bevacizumab for Central Retinal Vein Occlusion With Poor Vision
NCT01053858
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
38
Enrollment
OTHER
Sponsor class
Conditions
Central Retinal Vein Occlusion With 20/200 or Worse Visual Acuity
Interventions
PROCEDURE:
intravitreal injection
Sponsor
Hallym University Medical Center